CARsgen-B (02171) has released its interim results for 2026, reporting revenue of approximately RMB 61.919 million, a year-on-year increase of 21.5%. The adjusted net loss came in at RMB 31.927 million, narrowing by 55.53% compared to the prior year period, while the loss attributable to owners of the parent stood at RMB 66.663 million, reflecting an 11.52% reduction year-on-year.

The company recorded a loss per share of RMB 0.13 for the period. According to the announcement, the revenue growth was primarily driven by higher sales volumes of Saikeze, while the reduction in adjusted net loss was mainly attributed to decreased administrative expenses.